evolocumab

5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
FDA
Exelixis
vemurafenib
aripiprazole lauroxil
Alkermes
evolocumab
Amgen
Bristol-Myers Squibb
Opdivo
Clovis Oncology
rociletinib
More Preliminary Signs That The New Cholesterol Drugs May Improve Outcomes
Forbes
Tue, 04/28/15 - 08:45 am
Amgen
Sanofi
Regeneron
PCSK9 inhibitors
alirocumab
evolocumab
11 promising drugs poised to be the next billion-dollar blockbusters
Yahoo/Business Insider
Sat, 03/28/15 - 10:26 am
Opdivo
Praluent
LCZ696
lumacaftor
Viekira Pak
evolocumab
Gardasil 9
brexpiprazole
Toujeo
Cosentyx
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
AbbVie
Amge
Astellas
Merck
Otsuka
Lundbeck
Vertex Pharmaceuticals
Why 2015 is the year of the biopharma blockbuster—with charts
BioPharma Dive
Tue, 03/24/15 - 10:29 am
biotech
Opdivo
Praluent
LCZ696
Ibrance
Viekira Pak
evolocumab
Gardasil 9
Bristol-Myers Squibb
Regeneron
Sanofi
Novartis
Pfizer
Vertex Pharmaceuticals
Merck
Amgen
AbbVie
Astellas
Amgen, Regeneron Stocks Go Up as Drugs Bring Cholesterol Down
Forbes
Tue, 03/17/15 - 08:47 am
Amgen
Regeneron
PCSK9 inhibitors
alirocumab
evolocumab
3 Leading Biotech Stocks Releasing Potential Catalyst Data This Week
24/7 Wall St
Mon, 03/16/15 - 09:16 am
Amgen
evolocumab
Biogen Idec
BIIB037
OCA
obeticholic acid
Intercept Pharmaceuticals
New Cholesterol Drugs: Highly Effective But Important Questions Remain
Forbes
Mon, 03/16/15 - 09:08 am
PCSK9 inhibitors
alirocumab
evolocumab
Amgen
Sanofi
Regeneron
Amgen scores a victory for PCSK9, halving cardio risks after one year
Fierce Biotech
Mon, 03/16/15 - 08:58 am
Amgen
PCSK9 inhibitors
evolocumab
Could Amgen's Next Drug Be Worth $100 Billion?
Investopedia
Sat, 03/14/15 - 02:35 pm
Amgen
evolocumab
Is This Amgen's Next Big Thing?
Investopedia
Tue, 03/3/15 - 07:55 am
Amgen
evolocumab
biosimilars
Sanofi and Regeneron Gain Edge on Amgen in Cholesterol Drug Race
Bloomberg
Mon, 01/26/15 - 08:08 am
Sanofi
Regeneron
Amgen
alirocumab
evolocumab
PCSK9 inhibitors
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
5 Potential Blockbuster Drugs Set To Launch In 2015
Investors.com
Thu, 01/8/15 - 08:15 am
Amgen
Regeneron
evolocumab
alirocumab
Alexion
asfotase alfa
Novartis
LCZ696
Pfizer
palbociclib
FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
Yahoo
Mon, 11/10/14 - 11:05 am
FDA
Amgen
evolocumab
Amgen Files Lawsuit Against Sanofi And Regeneron For Patent Infringement
Yahoo
Fri, 10/17/14 - 09:56 am
Amgen
Sanofi
Regeneron
patents
alirocumab
monoclonal antibodies
evolocumab
Amgen: Why Its New Drug Application is a Big Deal
Barron's
Thu, 08/28/14 - 07:23 pm
Amgen
evolocumab
PCSK9 inhibitors
Amgen submits U.S. application to sell cholesterol-fighting drug
Yahoo/Reuters
Thu, 08/28/14 - 10:28 am
Amgen
PCSK9 inhibitors
evolocumab
As race to market intensifies, how expectant are cardiologists for PCSK9 inhibitor class?
First Word Pharma
Wed, 08/6/14 - 10:11 am
cardiologists
physicians
PCSK9 inhibitors
Sanofi
Regeneron
Amgen
evolocumab
alirocumab
FirstWord Lists: Pharma's biggest pipeline drugs
First Word Pharma
Mon, 08/4/14 - 11:53 am
pipelines
nivolumab
Pembrolizumab
evolocumab
palbociclib
cancer
breast cancer
Pfizer
Bristol-Myers Squibb
Merck
Amgen
3 Undervalued Amgen Growth Opportunities to Watch
Motley Fool
Mon, 06/16/14 - 09:03 pm
Amgen
evolocumab
Kyprolis
brodalumab
AMG-334

Pages